Top branded biologic drugs in the U.S. that will go generic by 2028
value of the pharmaceutical market in the United States falling by an estimated 22 billion U.S. dollars.
AbbVie, the company that manufactures Humira, generated 8.5 billion U.S. dollars from sales of the drug in 2015. AbbVie lost the initial patent to the drug a year later, and the impact of this, and all other expiring patents during 2016, led to the